LRP and Outcome of Induction Chemotherapy
| . | No. of Patients . | Complete Remission . | Resistant Disease . | Early Death . | Not Evaluable . |
|---|---|---|---|---|---|
| Total | 82 | 59 (72%) | 9 (11%) | 10 (12%) | 4 (5%) |
| LRP− patients | 53 | 43 (81%) | 4 (8%) | 5 (9%) | 1 (2%) |
| LRP+ patients | 29 | 16 (55%) | 5 (17%) | 5 (17%) | 3 (11%) |
| . | No. of Patients . | Complete Remission . | Resistant Disease . | Early Death . | Not Evaluable . |
|---|---|---|---|---|---|
| Total | 82 | 59 (72%) | 9 (11%) | 10 (12%) | 4 (5%) |
| LRP− patients | 53 | 43 (81%) | 4 (8%) | 5 (9%) | 1 (2%) |
| LRP+ patients | 29 | 16 (55%) | 5 (17%) | 5 (17%) | 3 (11%) |
LRP expression of leukemic cells was compared with outcome of induction chemotherapy. Induction chemotherapy protocols are described in Patients and Methods. Statistical analysis (chi-squared test) for complete remission: P = .01.